50. Dermatomyositis Clinical trials / Disease details


Clinical trials : 194 Drugs : 244 - (DrugBank : 89) / Drug target genes : 50 - Drug target pathways : 151

  
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03582800
(ClinicalTrials.gov)
January 6, 202013/6/2018Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot StudySubcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot StudySystemic Sclerosis;Dermatomyositis;iPPSD2Drug: STSUniversity Hospital, LimogesNULLRecruiting6 MonthsN/AAll40Phase 2France
2EUCTR2018-001978-22-FR
(EUCTR)
31/07/201917/09/2018Injections of Sodium Thiosulfate for ectopic calcifications or ossifications. A pilot study.Injections of Sodium Thiosulfate for ectopic calcifications or ossifications. A pilot study. - ITS Pilot Patient presenting with: - ectopic ossification secondary to iPPSD2 or - ectopic calcification secondary to dermatomyositis or - ectopic calcification secondary to systemic sclerosis
MedDRA version: 20.0;Level: LLT;Classification code 10006935;Term: Calcification and ossification, unspecified;System Organ Class: 100000004867 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
Trade Name: Sodium Thiosulfate 10%
Product Name: Sodium thiosulfate
INN or Proposed INN: Sodium thiosulfate 10%
Other descriptive name: SODIUM THIOSULFATE PENTAHYDRATE
CHU de LIMOGESNULLAuthorised-recruitment may be ongoing or finished Female: yes
Male: yes
40 Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): noFrance
3NCT03267277
(ClinicalTrials.gov)
October 5, 201729/8/2017Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult DermatomyositisAn Open-label Study of Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult DermatomyositisDermatomyositis;Idiopathic Inflammatory MyopathiesDrug: Sodium ThiosulfateNational Institute of Environmental Health Sciences (NIEHS)NULLActive, not recruiting7 YearsN/AAll14Phase 2/Phase 3United States
4NCT01572844
(ClinicalTrials.gov)
August 20124/4/2012Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated CalcinosisNovel Drug Delivery of Sodium Thiosulfate for Calcinosis Associated With Adult and Juvenile DermatomyositisCalcinosisDevice: Fractionated Carbon Dioxide (FCO2) Laser;Drug: Sodium thiosulfateAlison EhrlichNULLCompleted18 Years65 YearsAll3Phase 2United States